Test a dye used during surgery to find head and neck cancer
Part of Cancer clinical trials.
This trial tests whether a single dose of an imaging dye (given during surgery) can help doctors find the unknown origin of head and neck cancer and check safety. It may help guide surgery and biopsies when the primary cancer location hasn’t been identified.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have confirmed head and neck cancer on biopsy, or a strong suspicion of it (as judged by the study doctor).
- You can have surgery for this cancer (the surgeon must feel imaging during the operation is possible).
- Your overall health is good enough for surgery (for example, not too ill, with adequate ability to follow the study visits).
- If you can get pregnant: you must have a negative pregnancy test and use reliable birth control during the study and for 6 months after.
- You agree not to drink alcohol starting 72 hours before the dye is given until the Day 10 visit (plus or minus about 2 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests two different imaging (scanning) methods to better detect head and neck cancer. Your results from the scans may help doctors see where disease is before standard surgery to remove lymph nodes in the neck.
This study tests a special PET/CT scan that may help doctors see the cancer more clearly in people with head and neck cancer, either at diagnosis or if it comes back.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This Phase 1 study tests a labelling of panitumumab with iodine (111In) to see how well it can identify lymph nodes in head and neck cancer before surgery. The goal is to improve lymph node staging (which can help guide treatment), with the main focus on safety and early performance.
This study tests whether a combination of a targeted antibody (panitumumab) and a special dye can help surgeons see cancer cells more clearly during surgery. It may help ensure that all cancer is removed.
This early-phase study compares a special imaging marker with a standard PET scan to help identify head and neck squamous cell carcinoma before surgery. It may help doctors see where cancer is (especially if lymph nodes look negative) so surgery planning can be more accurate.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.